VALANX Biotech develops a proprietary technology for site-specific protein conjugation for applications in therapeutics, diagnostics and biocatalysis.

RebelBio

SOSV

aws Fondsmanagement GmbH

IST cube

tecnet equity

VALANX Biotech

Exuberant to have won the Boehringer Ingelheim innovation prize here at #meet2win in Bordeaux! Thank you to the jury for selecting us and thank you also to our great team making great science possible!

🏗️ VALANX Biotech's breaks walls on new facility

We're delighted to share that construction has commenced at our upcoming Vienna facility, creating new growth opportunities for VALANX.

Located in the heart of Vienna, this new facility will provide us with the necessary space for advanced research, development, and collaboration. We're on track for a planned move at the start of 2024, with meticulous planning guiding each step of the way.

A huge thank you to everyone who has contributed to making this project a reality. Stay tuned for more updates as we continue to grow and innovate at VALANX Biotech! 🚀

#VALANXBiotech #ViennaFacility #ConstructionUpdate #Innovation #BiotechGrowth #ResearchAndDevelopment #CollaborationSpace #2024Move #Teamwork #VALANXInnovates #BiotechExpansion

We are hiring! Want to join a dynamic, international and eager team and revolutionize protein conjugation? Seek no further, we have got you covered.

#job #labtechnician #proteins #synbio #syntheticbiology #startup #growth #team #hiring 

https://lnkd.in/g-D-E_Fy

🚀 Exciting Times at VALANX Biotech! 🧬
 
We are thrilled to share that we recently concluded a highly productive and energizing workshop at VALANX Biotech that has set the stage for our rapid acceleration and growth! 🌱💡
 
During this workshop, our entire team gathered to define organisational goals and processes and chart a course for the road ahead. By recognizing and capitalizing on the diversity within our organization, we are better equipped than ever to meet the complex challenges head on and drive meaningful change. ✨
 
We want to express our deep appreciation to every member of VALANX Biotech team for their active participation and dedication during this transformative workshop. It is through your unwavering commitment and dedication that we are poised to make a lasting impact on human health and well-being. Together, we are revolutionizing protein conjugation and shaping a better future for all. 🌟💙
 
#Biotech #Innovation #Teamwork #FutureofHealthcare #StartupSuccess

We are honoured to present Gabriela Staber as a member of our advisory board. Gabriela is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications). 

In addition to dispute resolution, her expertise includes criminal prosecution of infringements, licensing of intellectual property rights, negotiation of cross-border and international agreements, protection of designs, know-how and trade secrets, management of trademark portfolios, employee inventions, software, advertising and product labelling as well as antitrust issues in connection with intellectual property rights. She regularly publishes in specialist journals and is co-author of commentaries on the European Union Trademark Regulation and the Community Design Regulation. 

Welcome and we are looking forward to fruitful work together!

We are thrilled to introduce you to our newly established Advisory Board!

We welcome Pascal Deschatelets, currently Co-Founder and CSO at Apellis Pharmaceuticals, as a member of our Advisory Board! Pascal has extensive experience in company building in the biotech industry and will support us in everything company strategy and development. We are looking forward to grow VALANX to a leader in site-specific conjugation together!

https://lnkd.in/dBjzDBm5

We are delighted to introduce Lea Leitner – our new Junior Scientist Protein Expression System Development.

Lea studied Biotechnology at University of Natural Resources and Life Sciences, Vienna (BOKU) and already collaborated with VALANX Biotech for her master’s thesis in the field of mammalian cell culture. She is fascinated by the complexity of biological networks and how all these processes are perfectly intertwined within a cell or a whole organism.

In her spare time, Lea is keen on doing outdoor sport such as running, hiking or skiing in winter. She is a devoted traveller, who is inspired by learning about other countries and cultures.

Welcome, Lea! We are happy to have you in our team!

#valanxteam #welcome #biotechnology

Congratulations to Maximilian Winkler for obtaining his Master’s Degree in Technical Chemistry at Technische Universität Wien!

It has been a long and hard way, and we are proud of the way you have passed it!

#biotech #team #startup #mastersdegree #congratulations

We have just released our end-of-year newsletter with a yearly review! And what a year it has been, amazing milestones have been achieved. Thank you to the whole team at VALANX Biotech for making these strides possible! 


David Alejandro Peña Navarro Marta Deneha Georg Altenbacher Alex Alton Mandy Neumann Andrés Magán García Katarina Belačić Stefan Lukesch



https://lnkd.in/dzYh8Gf7

#biotech #team #thankyou #startup #synbio #syntheticbiology #therapeutics #happynewyear #happyholidays

VALANX Biotech is a synthetic biology company specializing in protein conjugation. They have developed a novel site-specific protein conjugation platform that allows precise control over conjugation site and number of conjugations on the protein of interest. They are developing cutting-edge biologics for potential treatments in various indications.

BIO:VALANX

VALANX Biotech

Filings Not Available